883 related articles for article (PubMed ID: 12516238)
21. Direct thrombin inhibition with Rec-hirudin CGP 39393 as prophylaxis of thromboembolic complications after total hip replacement.
Eriksson BI; Kälebo P; Ekman S; Lindbratt S; Kerry R; Close P
Thromb Haemost; 1994 Aug; 72(2):227-31. PubMed ID: 7831657
[TBL] [Abstract][Full Text] [Related]
22. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Matsukawa R; Kawashima Y
Circulation; 1997 Nov; 96(9 Suppl):II-376-81. PubMed ID: 9386127
[TBL] [Abstract][Full Text] [Related]
23. [Prophylaxis for deep vein thrombosis with low molecular weight heparin following hip and knee surgery].
Li XL; Lu WJ; Yu NS
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Jan; 15(1):39-41. PubMed ID: 12563929
[TBL] [Abstract][Full Text] [Related]
24. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.
Golański R; Golański J; Chizyński K; Iwaszkiewicz A; Zasłonka J; Pietrucha T; Chrul S; Watała C
Med Sci Monit; 2000; 6(4):722-8. PubMed ID: 11208399
[TBL] [Abstract][Full Text] [Related]
25. Fibrinolytic parameters in patients undergoing total hip replacement: relationship with the development of asymptomatic deep vein thrombosis and diagnostic usefulness of venous occlusion.
Trotti R; Siragusa S; Rondanelli M; Chezzi L; Citterio A; Melzi d'Eril GV; Piovella F
Haematologica; 1997; 82(2):178-81. PubMed ID: 9175322
[TBL] [Abstract][Full Text] [Related]
26. Differential diagnosis of localized and systemic amyloidosis based on coagulation and fibrinolysis parameters.
Suga N; Miura N; Kitagawa W; Morita H; Banno S; Imai H
Amyloid; 2012 Jun; 19(2):61-5. PubMed ID: 22417630
[TBL] [Abstract][Full Text] [Related]
27. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation.
Livingston ER; Fisher CA; Bibidakis EJ; Pathak AS; Todd BA; Furukawa S; McClurken JB; Addonizio VP; Jeevanandam V
Circulation; 1996 Nov; 94(9 Suppl):II227-34. PubMed ID: 8901751
[TBL] [Abstract][Full Text] [Related]
28. Coagulation and fibrinolysis activation after single-incision versus standard laparoscopic cholecystectomy: a single-center prospective case-controlled pilot study.
Zezos P; Christoforidou A; Kouklakis G; Tsalikidis C; Dimakis C; Laftsidis P; Virgiliou A; Simopoulos C; Pitiakoudis M
Surg Innov; 2014 Feb; 21(1):22-31. PubMed ID: 23575915
[TBL] [Abstract][Full Text] [Related]
29. [Thrombin-antithrombin complexes and F1+2 prothrombin fragment in coronary revascularization surgery. Relationship with graft occlusion].
Rifón J; Collados MT; Montes R; Chordá C; Páramo JA; Rocha E
Sangre (Barc); 1992 Aug; 37(4):259-63. PubMed ID: 1514139
[TBL] [Abstract][Full Text] [Related]
30. The impact of cardiac ischemia and reperfusion on markers of activated haemostasis and fibrinolysis during cardiopulmonary bypass: comparison of plasma levels in arterial and coronary venous blood.
Kalweit G; Bach J; Huwer H; Winning J; Hellstern P
Thromb Res; 2005; 116(1):33-9. PubMed ID: 15850606
[TBL] [Abstract][Full Text] [Related]
31. Prothrombin fragment 1+2 in urine as an indicator of sustained coagulation activation after total hip arthroplasty.
Borris LC; Breindahl M; Ryge C; Sommer HM; Lassen MR;
Thromb Res; 2007; 121(3):369-76. PubMed ID: 17599394
[TBL] [Abstract][Full Text] [Related]
32. Subclinical activation of coagulation and fibrinolysis in laparoscopic cholecystectomy: do risk factors exist?
Ntourakis D; Sergentanis TN; Georgiopoulos I; Papadopoulou E; Liasis L; Kritikos E; Tzardis P; Laopodis V
Int J Surg; 2011; 9(5):374-7. PubMed ID: 21371576
[TBL] [Abstract][Full Text] [Related]
33. Markers of hemostatic system activation during thromboprophylaxis with recombinant hirudin in total hip replacement.
Cofrancesco E; Cortellaro M; Leonardi P; Corradi A; Ravasi F; Bertocchi F
Thromb Haemost; 1996 Mar; 75(3):407-11. PubMed ID: 8701398
[TBL] [Abstract][Full Text] [Related]
34. The effect of total hip/knee replacement surgery and prophylactic dabigatran on thrombin generation and coagulation parameters.
Green L; Lawrie AS; Patel R; Stephens RC; Mackie IJ; Chitolie A; Haddad FS; Machin SJ
Thromb Res; 2012 Nov; 130(5):775-9. PubMed ID: 22245224
[TBL] [Abstract][Full Text] [Related]
35. Changes in the coagulation and fibrinolytic systems during and after cardiopulmonary bypass surgery.
Kongsgaard UE; Smith-Erichsen N; Geiran O; Bjørnskau L
Thorac Cardiovasc Surg; 1989 Jun; 37(3):158-62. PubMed ID: 2527423
[TBL] [Abstract][Full Text] [Related]
36. Coagulation activation and reactive fibrinolysis in patients receiving oral anticoagulation after total hip or knee replacement.
van Wersch JW; de Vries-Hanje JC; Oosterbos C
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):605-8. PubMed ID: 7841318
[TBL] [Abstract][Full Text] [Related]
37. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.
Appel IM; Hop WC; van Kessel-Bakvis C; Stigter R; Pieters R
Thromb Haemost; 2008 Aug; 100(2):330-7. PubMed ID: 18690355
[TBL] [Abstract][Full Text] [Related]
38. Coagulation changes following hepatic revascularization during liver transplantation.
Harper PL; Luddington RJ; Jennings I; Reardon D; Seaman MJ; Carrell RW; Klink JR; Smith M; Rolles K; Calne R
Transplantation; 1989 Oct; 48(4):603-7. PubMed ID: 2529679
[TBL] [Abstract][Full Text] [Related]
39. [Effect of different analgesia combined with low molecular heparin on hemorheology and coagulation in patients undergoing total hip replacement].
Lou XK; Yan MJ
Zhonghua Yi Xue Za Zhi; 2010 May; 90(17):1171-6. PubMed ID: 20646562
[TBL] [Abstract][Full Text] [Related]
40. [Clinical risk factors for deep vein thrombosis after total hip and knee arthroplasty].
Guan ZP; Lü HS; Chen YZ; Song YN; Qin XL; Jiang J
Zhonghua Wai Ke Za Zhi; 2005 Oct; 43(20):1317-20. PubMed ID: 16271243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
